GovChime

CFSAN-2022-112374 DFPST ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA)

Overview

Response deadline
12:00 PM UTC−04:00
Posted
July 27, 2022
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA Office of Acquisitions and Grants Services
Place of performance
Summit Argo, IL, 60501
Last updated
Dec 4, 2025

Identifiers

Solicitation number
FDA-RFQ-CFSAN-2022-112374
Notice ID
9798b1f6cca34324bb3587e27c903206

Description

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure an ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA), under solicitation FDA-RFQ-CFSAN-2022-112374, per attached solicitation.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:FDA-RFQ-CFSAN-2022-112374
  1. Combined Synopsis
  1. Combined SynopsisCurrentJul 27, 2022

    CFSAN-2022-112374 DFPST ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA)

    Notice 9798b1f6cca34324bb3587e27c903206 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDA-RFQ-CFSAN-2022-112374

Archive Date

Aug 25, 2022

Office Address

Rockville, MD, 20857